ORTHOGEN LAB SERVICES GMBH

ORTHOGEN Lab Services GmbH is a German company based in Düsseldorf and a 100% subsidiary of ORTHOGEN AG.

Orthopedics and pain therapy are the first and most active research areas of ORTHOGEN. Our methods have been clinically applied in these areas for over 25 years. Molecular orthopaedics, as the main component of our research, has long shown that many orthopaedic diseases are conditions that are not only caused by mechanical wear but result from a complex interaction of molecular and biochemical signals. Most orthopedic diseases are affected in the short or long term by inflammation, other biomolecular changes and often by a regenerative deficiency. We try to understand the basic molecular causes of pain and disease in order to enable targeted causal treatments. We follow a comprehensive and physiological approach to restore the natural balance and healthy conditions in diseased tissue. We aim to provide sustainable, non-surgical, individualized treatment alternatives.

1993

Foundation of ORTHOGEN Gentechnologie in Düsseldorf with focus on molecular orthopedics

1996

Development of the Orthokine syringe

2002

Foundation of ORTHOGEN Lab Services GmbH as a sales company

2004

Development and market launch of the EOT syringe

2004

First study publications on Orthokine therapy

2008

Market launch of the EOT II syringe

2013

Internationalization

2015

Over 400,000 medical devices sold worldwide

2015 - 2019

Further milestones in the publication of studies

employees

years experience

customers

patients worldwide

Our Team

Lars Nierbauer

Lars Nierbauer

Managing Director & Key Account Management Austria & South Germany

Holger Stephan

Holger Stephan

Managing Director

Amelie Behn

Amelie Behn

Key Account Management North Germany

Vesna Seemann

Vesna Seemann

Key Account Management Central Germany